Tempus AI Inc header image

Tempus AI Inc

TEM

Equity

ISIN null / Valor 135855934

NASDAQ (2026-02-18)
USD 56.16+6.85%

Tempus AI Inc
UMushroom community rating:

star star star star star
4.00 1 votes No rating yet
NegativeNeutralPositive

About company

Tempus AI Inc., founded in August 2015 by Eric Lefkofsky, is a technology company specializing in the application of artificial intelligence to cancer care. The company aims to harness real-time healthcare data to personalize diagnostics and treatment plans for cancer patients. With the recruitment of its first employee, Ryan Fukushima, Tempus has focused on developing a robust platform that integrates and analyzes vast amounts of clinical and molecular data. This platform is designed to provide actionable insights to healthcare providers, thereby improving patient outcomes through more precise and tailored treatment strategies.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-31.5%1Y
%3Y
%5Y

Performance

83.9%1Y
102%3Y
102%5Y

Volatility

Market cap

9708 M

Market cap (USD)

Daily traded volume (Shares)

6,872,636

Daily traded volume (Shares)

1 day high/low

34.57 / 32.97

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

1 votes
Performance:
starstarstarstarstar
4.00
Innovation:
starstarstarstarstar
4.00
Society:
starstarstarstarstar
4.00
Nature:
starstarstarstarstar
4.00
Winston Hu
United Kingdom, 03 Nov 2025
star star star star star
High potential within this stock

EQUITIES OF THE SAME SECTOR

Ambea AB
Ambea AB Ambea AB Valor: 36138415
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.92%SEK 122.00
Vimian Group AB
Vimian Group AB Vimian Group AB Valor: 111662981
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.04%SEK 26.52
Inari Medical Inc
Inari Medical Inc Inari Medical Inc Valor: 52764794
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 79.97
Alcon Inc.
Alcon Inc. Alcon Inc. Valor: 43249246
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.40%CHF 63.92
BACHEM HOLDING LTD
BACHEM HOLDING LTD BACHEM HOLDING LTD Valor: 117649372
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.15%CHF 66.10
Newron Pharmaceuticals S.p.A.
Newron Pharmaceuticals S.p.A. Newron Pharmaceuticals S.p.A. Valor: 2791431
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-7.71%CHF 19.38
EssilorLuxottica SA
EssilorLuxottica SA EssilorLuxottica SA Valor: 497537
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.31%EUR 233.00
bioMerieux SA
bioMerieux SA bioMerieux SA Valor: 38147803
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.11%EUR 94.30
Siemens Healthineers AG
Siemens Healthineers AG Siemens Healthineers AG Valor: 40652181
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.64%EUR 41.50
Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA Fresenius SE & Co. KGaA Valor: 332902
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.58%EUR 51.82